Pfizer’s hemophilia B gene therapy is better than standard of care in phase 3 trial
![](https://amspredict.com/wp-content/uploads/2023/11/GettyImages-1369661925-2-300x169-1.png)
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)
Early Win for Gene Therapy in Rare Form of SCID — 10 infants were able to make their own T cells; safety good so far
![](https://amspredict.com/wp-content/uploads/2023/11/102358-300x169-1.png)
As Congress, the U.S. Federal Trade Commission (FTC), and industry are taking a closer look at pharmacy benefit managers (PBMs)